List of works by Robert Flisiak

A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin.

scientific article

A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C.

scientific article

A pill for HCV - myth or foreseeable future?

scientific article published on 02 September 2013

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection

scientific article published on 24 July 2014

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

scientific article published on July 2011

Acute hepatitis E complicated by acute pancreatitis: a case report and literature review.

scientific article published in May 2005

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference

scientific article published on February 2016

Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.

scientific article

Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C.

scientific article

Albinterferon-alfa 2b: a new treatment option for hepatitis C ⬇️

scientific article published on October 1, 2010

Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

scientific article

Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial.

scientific article published on 21 November 2014

Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism.

scientific article published on June 2015

Annex #1 as of 8 June 2020 to: Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020

scientific article published on 08 June 2020

Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations

scientific article published on August 2010

Assessment of serum IGF-1 and adipokines related to metabolic dysfunction in HIV-infected adults.

scientific article published on 12 August 2013

Association among Fas expression in leucocytes, serum Fas and Fas-ligand concentrations and hepatic inflammation and fibrosis in chronic hepatitis C

scientific article published on 16 November 2009

Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions

scientific article published on 01 August 2002

Blood platelet function abnormalities in cirrhotic patients with esophageal varices in relation to the variceal bleeding history

scientific article published on 23 March 2019

Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial

scientific article published on 26 May 2016

Chance of hepatic fibrosis treatment in chronic hepatitis C

scientific article published in January 2004

Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection

scientific article published on 07 February 2020

Changes in serological biomarkers of liver function and connective tissue turnover in chronic hepatitis B during lamivudine therapy

scientific article published in November 2005

Changing HCV genotypes distribution in Poland--relation to source and time of infection.

scientific article published on 19 March 2008

Chronic HBV infection in patients with lymphoproliferative syndromes

scientific article published in January 2012

Chronic Viral Hepatitis and Metabolic Syndrome/Cardiovascular Risk

article published in 2018

Chronic hepatitis B virus infection is associated with decreased serum 25(OH)D concentration in non-cirrhotic patients

scientific article published on 20 February 2019

Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis

scientific article published on 01 June 2000

Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment

scientific article published on 25 July 2008

Clinical Usefulness of the Inhibitory Control Test (ICT) in the Diagnosis of Minimal Hepatic Encephalopathy

scientific article published on 22 May 2020

Clinical course of Lyme borreliosis with respect to the initial disease manifestation in Białowieza residents

scientific article published in January 2004

Clinical importance and diagnostic methods of minimal hepatic encephalopathy

scientific article published on February 2016

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B.

scientific article published on 7 October 2015

Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

scientific article published on 13 December 2019

Computed tomography changes in lungs of COVID-19 patients

scientific article published on 18 May 2020

Convalescent Plasma Transfusion for the Treatment of COVID-19-Experience from Poland: A Multicenter Study

scientific article published on 24 December 2020

Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

article

Correction: Quantitative measurement of HCV core antigen for management of interferon-free therapy in HCV-infected patients

scientific article published on 01 January 2018

Cost-effectiveness of truncated therapy for hepatitis C based on rapid virologic response

scientific article published on 9 August 2012

Current drugs in early development for treating hepatitis C virus-related hepatic fibrosis

scientific article published on 30 June 2015

Cyclophilin inhibitors in hepatitis C viral infection

scientific article published on September 2007

Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1

scientific article published on March 2016

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin

scientific article published on 14 February 2013

Delayed HIV disease diagnosis, despite multiple hospitalizations--case report

scientific article

Delayed diagnosis of human immunodeficiency virus infection in a patient with non-specific neurological symptoms and pancytopenia: a case report

scientific article published on 24 March 2014

Distribution of HBV genotypes in Poland

scientific article published on 30 April 2015

Distribution of HCV genotypes in Poland

scientific article published in January 2013

Drug rash with eosinophilia and systemic symptoms after ibuprofen intake.

scientific article published in January 2007

Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience study

scientific article published on 03 July 2018

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

scientific article published on August 2010

Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination

scientific article published on 15 November 2021

Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis: A Multicenter Cohort Study.

scientific article

Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C - a real-world study

scientific article published on 05 September 2019

Effect of hepatitis B virus (HBV) infection on the course of pregnancy and newborns' health status

scientific article published on 16 November 2015

Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B

scientific article

Effect of misoprostol on serum beta2-microglobulin in the course of viral hepatitis B

scientific article published on 01 November 1999

Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.

scientific article

Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta1

scientific article published on 01 June 2001

Effect of ulcerative colitis treatment on transforming growth factor beta(1) in plasma and rectal mucosa

scientific article published in May 2003

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics

scientific article

Effectiveness and safety of ledipasvir/sofosbuvir±ribavirin in the treatment of HCV infection: The real-world HARVEST study.

scientific article published on 26 May 2017

Effects of ethanol on prostanoid production by liver fat-storing cells

scientific article published on 01 July 1993

Effects of ulcerative colitis activity on plasma and mucosal prostaglandin E2 concentration

scientific article published on 01 October 1999

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Co-infected with Hepatitis C Virus and Human Immunodeficiency Virus-1: the EXPEDITION-2 Study.

scientific article published on 16 March 2018

Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.

scientific article published on 16 August 2016

Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection

scientific article published on 10 December 2019

Efficacy and safety of vaccination against yellow fever of persons traveling to endemic areas

scientific article published on January 1, 2010

Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study

scientific article published on 28 November 2016

Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection

scientific article

Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation.

scientific article

Emerging treatments for hepatitis C.

scientific article published on 08 October 2013

Epidemiological and clinical characteristics of genotype 4 HCV infection in the north-east Poland

scientific article published in January 2009

Epidemiological characteristics of inflammatory bowel disease in North-Eastern Poland.

scientific article

Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland

scientific article published on March 2011

Epidemiology of intra-marital infections with hepatitis B virus (HBV) among the patients hospitalized in the infectious disease clinics in the Białystok region 1988-1990

scientific article published on January 1, 1991

Epidemiology, diagnosis, and prevention of tick-borne encephalitis in Poland and selected european countries – a position statement of the polish group of experts

scientific article published on 17 February 2021

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.

scientific article published on 25 November 2015

Evaluation of alpha-glutathione-S-transferase as a biomarker of lamivudine therapy for chronic hepatitis B

scientific article published on 01 October 2006

Exacerbation of chronic hepatitis B during chemotherapy due to testicular seminoma

scientific article published in June 2012

Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy

scientific article published on 12 February 2017

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study

scientific article published on 01 May 2021

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

scientific article published on 10 April 2020

Forecasting the disease burden of chronic hepatitis C virus in Poland

scientific article published on January 2015

Galectin-3 Concentration in Liver Diseases

scientific article

Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study

scientific article published in 2019

Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

scientific article published in January 2018

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

scientific article published in June 2018

Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir

scientific article published in January 2015

HBV mutations and their clinical significance.

scientific article published on June 2012

HBV mutations associated with lamivudine therapy

scientific article published in January 2013

HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study

scientific article published on 13 January 2022

HCV entry as a new therapeutic target in chronic hepatitis C

scientific article published in August 2009

Helicobacter pylori infection among patients with liver cirrhosis

scientific article published on 11 July 2017

Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

scientific article published on 22 August 2018

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

scientific article published on 13 February 2010

Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection

scientific article

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study

scientific article published in September 2022

Hepatitis C virus core antigen as a possible alternative for evaluation of treatment effectiveness after treatment with direct-acting antivirals

scientific article published on 06 September 2019

Hepatitis C: efficacy and safety in real life.

scientific article published on January 2017

High concentration of antimitochondrial antibodies predicts progressive primary biliary cirrhosis

scientific article published on September 2005

High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland.

scientific article published in April 2008

High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance

scientific article published on 11 May 2014

High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases

scientific article published on 30 September 2017

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2.

scientific article published on January 2015

How close are we to hepatitis C virus elimination in Central Europe?

scientific article published on 17 February 2020

Hyaluronic acid concentration in liver diseases.

scientific article published on 09 September 2015

Immune regulation and viral diversity as correlates of natural and treatment induced immune control in persistent hepatitis B virus (HBV) infection

scientific article published on 02 June 2015

Impact of rs12979860 polymorphism on liver morphology in chronic HCV infection

scientific article published on 30 April 2015

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

scientific article published on 6 October 2017

Incidence of tuberculosis and mycobacteriosis among HIV-infected patients--clinical and epidemiological analysis of patients from north-eastern Poland

scientific article published on January 2013

Increased plasma transforming growth factor-beta1 is associated with disease progression in HIV-1-infected patients.

scientific article published in January 2004

Influence of HCV and HIV on development of cryoglobulinemia

scientific article published on 27 February 2015

Investigational drugs for hepatitis C.

scientific article published on January 2010

Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?

scientific article published in February 2018

Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all HCV infected patients in the real-world experience?

scientific article published on 10 November 2020

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate

scientific article published on 18 July 2014

Knowledge is coming so fast that a meta-analysis of COVID-19 treatment is always too late

scientific article published on 30 September 2020

Known and probable risk factors for hepatitis C infection: a case series in north-eastern Poland

scientific article

Laboratory evidence for hypercoagulability in cirrhotic patients with history of variceal bleeding

scientific article published on 01 April 2019

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

scientific article

Long-term effects of HBV treatment Peg-IFN alfa-2a alone or combined with lamivudine

scientific article published in January 2007

Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders

scientific article published in September 2012

Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA

scientific article published on 13 June 2020

Lyme borreliosis

scientific article published in January 2012

Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020

scientific article published on 29 October 2020

Management of hepatitis B and hepatitis C coinfection: an expert review

scientific article published on 24 June 2020

Meeting of Initiative Group for Central European Hepatologic Collaboration (CEHC): Warsaw, 19-21 November 2015

scientific article published on 24 March 2016

Metabolic abnormalities and cardiovascular risk in HIV-infected cohort of patients treated with protease inhibitors

scientific article published in 2015

Metabolic syndrome and hepatitis C infection--brothers in arms.

scientific article published on 19 June 2013

Metabolic syndrome in HIV infected adults in Poland.

scientific article published on 19 January 2018

Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.

scientific article published in January 2007

Morphological studies of the effects of protein-free diet and branched-chain amino acids (aminosteril-hepa (Frasenius)) on experimental thioacetamide-induced liver damage

scientific article published in January 1990

New therapeutic options for HCV in Central Europe

scientific article published on 24 March 2016

Normalizing serum hepcidin but not α-1-antitrypsin level during effective treatment of chronic hepatitis C

scientific article published on 16 November 2017

Occurrence and clinical characteristics of hepatocellular carcinoma in the north-eastern Poland

scientific article

Ombitasvir and paritaprevir boosted with ritonavir and combined with dasabuvir for chronic hepatitis C.

scientific article published on 20 March 2017

Ombitasvir/paritaprevir/ritonavir plus dasabuvir combination in the treatment of chronic HCV infection.

scientific article published on 11 April 2016

Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study

scientific article

One year follow-up of patients treated with misoprostol in acute phase of viral hepatitis B.

scientific article published in March 2000

Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients

scientific article published on 08 July 2019

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection

scientific article published on 13 January 2022

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

scientific article published in June 2005

Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b.

scientific article

Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis

scientific article

Perspectives of hepatitis C virus (HCV) elimination in Poland

scientific article published on 05 September 2019

Plasma iPGE2 and i6-keto PGF1 alpha in the course of liver cirrhosis

scientific article published on 01 January 1997

Plasma interleukin-18 is associated with viral load and disease progression in HIV-1-infected patients

scientific article published on 01 November 2004

Plasma interleukin-18 reflects severity of ulcerative colitis.

scientific article

Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity.

scientific article

Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis

scientific article published on 01 September 2002

Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B

scientific article published on 01 November 2005

Plasma transforming growth factor β1as a biomarker of psoriasis activity and treatment efficacy ⬇️

scientific article published on September 1, 2003

Plasma transforming growth factor-beta(1) in acute viral hepatitis.

scientific article published on 25 May 2005

Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe

scientific article published on 5 January 2010

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.

scientific article

Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern Poland

scientific article

Prevalence and risk factors of HCV infection in Poland

scientific article published in November 2011

Prevalence of HCV genotypes in Poland - the EpiTer study

scientific article published on 28 November 2016

Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function

scientific article published on 7 July 2009

Prevalence of syphilis among patients living with HIV treated in Bialystok HIV/AIDS Center

scientific article published in 2017

Prevalence, clinical and therapeutical implications of active CMV infection in patients with chronic hepatitis C

scientific article published in January 2009

Prophylaxis of hepatitis B virus (HBV) infection reactivation - recommendations of the Working Group for prevention of HBV reactivation

scientific article published on 05 September 2019

Quantitative measurement of HCV core antigen for management of interferon-free therapy in HCV infected patients

scientific article published on 10 October 2017

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II).

scientific article

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3.

scientific article published on 21 March 2012

Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial

scientific article published in January 2011

Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy

scientific article published on 03 March 2019

Real-World Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir/+Dasabuvir±Ribavirin (OBV/PTV/r/+DSV±RBV) Therapy in Recurrent Hepatitis C Virus (HCV) Genotype 1 Infection Post-Liver Transplant: AMBER-CEE Study

scientific article published on 7 April 2017

Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study.

scientific article published on 9 September 2016

Real-world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A meta-analysis

scientific article published on 8 May 2017

Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4.

scientific article

Real-world experience with ombitasvir/paritaprevir boosted with ritonavir and possibly combined with dasabuvir and ribavirin in HCV infection

scientific article published on 06 June 2016

Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational

scientific article published on 05 March 2019

Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)

Recommendations for the treatment of hepatitis B in 2017

scientific article published on 10 May 2017

Recommendations for the treatment of hepatitis C Polish group of HCV Experts--2015

scientific article published in January 2015

Recommendations for the treatment of hepatitis C in 2017

scientific article published on 18 May 2017

Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016

scientific article published on 07 April 2016

Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015

scientific article published on 16 November 2015

Recommendations of management in SARS-CoV-2 infection of the Polish Association of Epidemiologists and Infectiologists

scientific article published on 31 March 2020

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020

scientific article published on 01 September 2020

Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy

scientific article published on 28 September 2022

Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study

scientific article published on 31 December 2020

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

scientific article published on 3 October 2017

Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe

scientific article published in 2017

Role of cannabinoids in chronic liver diseases

scientific article published on October 2008

SNP RS12979860 related spontaneous clearance of hepatitis c virus infection in HCV/HIV-1 coinfected patients.

scientific article published on January 2013

Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials

scientific article published on 20 February 2019

Searching for the optimal population for hepatitis C virus screening in Poland

scientific article published on 30 April 2020

Selected Noninvasive Markers in Diagnosing Liver Diseases

scientific article published on 29 December 2015

Selected indices of immunoreactivity dependent on HBV infection in patients with alcoholic liver cirrhosis

scientific article published on April 1, 1991

Serum Concentrations of Th17-Associated Interleukins and Autoimmune Phenomena are Associated with the Degree of Liver Damage in Alcoholic Liver Disease

scientific article published on September 2017

Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease

scientific article published on 30 July 2017

Serum HCV core antigen concentration in HCV monoinfection and HCV/HIV coinfection

scientific article

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.

scientific article published on 28 August 2013

Serum level of interleukin-6 (IL-6) and N-terminal propeptide of procollagen type I (PINP) in patients with liver diseases

scientific article published on 22 December 2017

Serum prohepcidin reflects the degree of liver function impairment in liver cirrhosis

scientific article published in August 2008

Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection.

scientific article published on 23 December 2014

Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland

scientific article published on 4 April 2022

Signal transduction pathways in liver and the influence of hepatitis C virus infection on their activities

scientific article

Significance of mutations in the region coding for NS3/4 protease in patients infected with HCV genotype 1b

scientific article published on 01 November 2018

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

scientific article published on 4 May 2014

Specific ssDNA concentration in liver tissue as an index of apoptosis in hepatitis C virus-infected patients.

scientific article published on October 2005

Specifically targeted antiviral therapy for hepatitis C virus

scientific article published on November 2007

Standards of hepatitis C treatment. Recommendations of Polish Group of Experts--2014

scientific article published on 01 January 2014

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.

scientific article published on January 2015

Successful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C.

scientific article

Telaprevir for previously untreated chronic hepatitis C virus infection

scientific article (publication date: 23 June 2011)

Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection

scientific article published on 10 July 2019

Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml).

scientific article published on 28 October 2014

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

scientific article published in December 2008

The Strategies to Support the COVID-19 Vaccination with Evidence-Based Communication and Tackling Misinformation

scientific article

The concentration of total sialic acid in chronic hepatitis B and C

scientific article published on 16 August 2018

The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.

scientific article published in May 2009

The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.

scientific article published in March 2008

The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins

scientific article

The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

scholarly article by Ewa Janczewska et al published 16 November 2018 in BMC Infectious Diseases

The importance of sCD40 and sCD40L concentration in patients with chronic HCV infection and HIV co-infection

scientific article published on January 2014

The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease

article

The justification for the early introduction of antiretroviral therapy in patients living with HIV.

scientific article published on January 2014

The occurrence of HCV genotypes and single polynucleotide polymorphisms of rs12979860 among HCV infected patients in northeastern Poland

scientific article published in January 2012

The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation

scientific article published on 28 November 2016

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.

scientific article published on January 2015

The transferrin isoforms in chronic hepatitis.

scientific article published on 30 June 2017

Therapeutic recommendations for 2013: antiviral treatment for chronic hepatitis B.

scientific article published in January 2013

Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection

scientific article published in January 2010

Therapeutic vaccination in chronic hepatitis B: chance or utopia?

scientific article published in December 2003

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

scientific article published on 16 October 2010

Thyroid dysfunction in antiviral therapy of chronic hepatitis C

scientific article published on 01 July 2010

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6

scientific article published on 9 April 2021

Tocilizumab for patients with severe COVID-19: a retrospective, multi-centre study

scientific article published on 22 July 2020

Total and free serum sialic acid concentration in liver diseases

scientific article

Transforming growth factor beta1 and prostaglandin E2 concentrations are associated with bone formation markers in ulcerative colitis patients.

scientific article

Transforming growth factor-beta1 as a surrogate marker of hepatic dysfunction in chronic liver diseases

scientific article published on 01 November 2000

Treatment of HCV infection in Poland at the beginning of the interferon-free era - the EpiTer-2 study

scientific article published on 6 January 2018

Treatment of chronic hepatitis C in a patient with Fanconi anaemia.

scientific article published in January 2011

Treatment recommendations of chronic hepatitis B. Did the world escape us?

scientific article published in January 2008

Update on alisporivir in treatment of viral hepatitis C.

scientific article published on 8 February 2012

Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3

scientific article published on 26 August 2011

[Activity of the caspase-3 in the culture of peripheral blood mononuclear cells stimulated with Borrelia burgdorferi antigens]

scientific article published on 01 January 2008

[Analysis of prognostic factors in patients with autoimmune hepatitis]

scientific article published on 01 April 2006

[Cytokeratin 18 as an indicator of the activity of liver disease]

scientific article published on 01 December 2011

[Diagnostics and treatment of Lyme borreliosis. Recommendations of Polish Society of Epidemiology and Infectious Diseases].

scientific article published in January 2008

[Effect of exposure to tick-bites on the course of lyme borreliosis in Bialowieza residents].

scientific article published in January 2002

[HBV infection and pregnancy]

scientific article published on 01 January 2010

[Influence of cryoglobulinaemia on renal function in patients with chronic HCV infection].

scientific article

[Liver damage in the course of Langerhans cells histiocytosis--case report]

scientific article published on 01 February 2012

[Occurrence of autoantibodies in patients with alcoholic liver disease]

scientific article published on 01 September 2012

[Polish Experts Group on HBV. Therapeutic recommendations on 2008 year (antiretroviral treatment of chronic hepatitis B)]

scientific article published on 01 January 2008

[Polish Group of Experts of HBV--collective to vaccinations: vaccinations against hepatitis A and B]

scientific article published on 01 January 2012

[Polish multicenter study on safety and efficacy of adefovir dipivoxil in the treatment of lamivudine resistant chronic hepatitis B in adults (HEP 2008)]

scientific article published on 01 January 2011

[Predictive factors of virological response in chronically HCV infected]

scientific article published on 01 September 2012

[Prevalence of antibodies against hepatitis E virus among students from India living in Bialystok, Poland]

scientific article published on 01 January 2008

[Respiratory functional impairment in patients with liver cirrhosis]

scientific article published on 01 November 2011

[Respiratory functional impairment in patients with liver cirrhosis]

scientific article published on 01 April 2010

[Standards of hepatitis C treatment. Recommendations of Polish Group of Experts]

scientific article published on 01 January 2012

siRNA drug development against hepatitis B virus infection

article

Paulina is supported by:

About Paulina

Help